Picture of Biopharmaceutical Venture Capital Trends: Coronavirus Disease (COVID-19) Company Impact Report

Biopharmaceutical Venture Capital Trends: Coronavirus Disease (COVID-19) Company Impact Report

New 2020 Report

$695.00

This report examines the impact of the COVID-19 pandemic on venture capital deals for biopharmaceutical companies. This analysis is critical to understanding how the outbreak of COVID-19 impacted investments and how those VC deal trends may impact current and future venture capital investments.

Scope

This 32-page report gives important, expert insight you won’t find in any other source. 11 tables and 9 figures throughout the report illustrate major points and trends. This report is required reading for:

• Investors that want to understand how COVID-19 has impacted VC deals in the biopharmaceutical industry as well as identifying companies that may be due for a round of financing in upcoming months

• Companies that are due to raise venture capital in the near future and need to consider 2020 VC trends into their capital raising strategies.

• Large pharma companies with investment groups or BD teams looking for partnership opportunities where companies may be in need of financing with changing VC trends during the COVID-19 pandemic.

Reasons to buy

Monthly trends of VC deals by value and volume; including an analysis of monthly VC activity in China versus U.S. during the spread of the diease

Analyzes how COVID-19 has shifted investment trends by deal value, round, and therapeutic area

Assessment of investors activity level in biopharmaceutical VC deals prior to and during the COVID-19 pandemic

Identify biopharmaceutical companies that may be looking for rounds of financing and how they may be impacted by the shifted trends in VC investment

Companies mentioned

4d Molecular Therapeutics

Adlai Nortye Biopharma Co Ltd.

AIVITA Biomedical, Inc.

Akouos Inc

Alexandria Venture Investments

Aligos Therapeutics Inc

ALX Oncology Inc

Amal Therapeutics SA

Annexon, Inc

Ansun BioPharma Inc

Antiva Biosciences

Apexigen, Inc.

Aqualung Therapeutics Corp

ARCH Venture Partners LP

ARS Pharmaceuticals, Inc.

Ascentage Pharma group

Atomwise Inc.

Biopact Cellular Transport Inc

Blueberry Therapeutics Ltd.

Boxer Capital

BW Therapeutics LLC

Cadent Therapeutics

Carisma Therapeutics Inc.

Casdin Capital LLC

Casma Therapeutics, Inc.

Celsense Inc

CerFlux Inc

Chondrial Therapeutics LLC

Cormorant Asset Management LLC

Cowen Healthcare Investments

Decibel Therapeutics, Inc.

Deerfield Management

ElevateBio LLC

Emulate Inc.

EQRx Inc

Escient Pharmaceuticals, Inc.

Evox Therapeutics Ltd

Fidelity Management & Research

Foresite Capital Management LLC

Freeline Therapeutics

Galecto Biotech AB

Galera Therapeutics Inc

Generation Bio Corp

Heartseed Inc

Horama SA

Hotspot Therapeutics, Inc

Hoverink Biotechnologies Inc

ILiAD Biotechnologies, LLC

Immune-Onc Therapeutics, Inc.

Immunocore Ltd

Impact Therapeutics

InCarda Therapeutics, Inc.

InSightec Ltd

Intarcia Therapeutics Inc

Intensity Therapeutics, Inc.

iTeos Therapeutics SA

KAHR medical Ltd

Kaitai Capital

Kallyope Inc

Kleo Pharmaceuticals Inc

Ksq Therapeutics, Inc

Kymera Therapeutics LLC

Lilly Asia Ventures

Max Biopharma Inc

Medicxi Ventures (UK) LLP

Metacrine, Inc.

Minoryx Therapeutics

Modalis Therapeutics Corporation

Nanjing Legend Biotech Co Ltd

NBE-Therapeutics AG

Neuraly, Inc

Neurana Pharmaceuticals, Inc.

Neurotez Inc

NMD Pharma ApS

Nohla Therapeutics, Inc.

Novo Holdings AS

Oncoheroes Biosciences Inc

OncoResponse, Inc.

Orasis Pharmaceuticals

Orbimed Advisors LLC

Partner Therapeutics, Inc

Perceptive Advisors

Phylos Bioscience Inc

Pliant Therapeutics Inc

Polaris Partners LLC

Quentis Therapeutics, Inc.

RA Capital Management LLC

Rakuten Medical Inc

Rallybio, LLC

ReAlta Life Sciences Inc

Redmile Group LLC

Relay Therapeutics

RemeGen Ltd

Rgenix, Inc

Rheos Medicines, Inc.

Ripple therapeutics Corp

Rongchang Bio-Pharmaceutical Co., Ltd

Sen-Jam Pharmaceutical LLC

Senti Biosciences, Inc

Sirnaomics, Inc.

Slayback Pharma LLC

SQZ Biotech

StemBioSys Inc

Surveyor Capital Ltd

SutroVax Inc

Synthego Corporation

Tecnologia Regenerativa Qrem SL

Transcenta Holding Ltd

Vedanta Biosciences, Inc.

Velicept Therapeutics, Inc.

Vivo Capital LLC

Xilio Therapeutics Inc

XtalPi, Inc.


This report examines the impact of the COVID-19 pandemic on venture capital deals for biopharmaceutical companies. This analysis is critical to understanding how the outbreak of COVID-19 impacted investments and how those VC deal trends may impact current and future venture capital investments.

Scope

This 32-page report gives important, expert insight you won’t find in any other source. 11 tables and 9 figures throughout the report illustrate major points and trends. This report is required reading for:

• Investors that want to understand how COVID-19 has impacted VC deals in the biopharmaceutical industry as well as identifying companies that may be due for a round of financing in upcoming months

• Companies that are due to raise venture capital in the near future and need to consider 2020 VC trends into their capital raising strategies.

• Large pharma companies with investment groups or BD teams looking for partnership opportunities where companies may be in need of financing with changing VC trends during the COVID-19 pandemic.

Reasons to buy

Monthly trends of VC deals by value and volume; including an analysis of monthly VC activity in China versus U.S. during the spread of the diease

Analyzes how COVID-19 has shifted investment trends by deal value, round, and therapeutic area

Assessment of investors activity level in biopharmaceutical VC deals prior to and during the COVID-19 pandemic

Identify biopharmaceutical companies that may be looking for rounds of financing and how they may be impacted by the shifted trends in VC investment

Companies mentioned

4d Molecular Therapeutics

Adlai Nortye Biopharma Co Ltd.

AIVITA Biomedical, Inc.

Akouos Inc

Alexandria Venture Investments

Aligos Therapeutics Inc

ALX Oncology Inc

Amal Therapeutics SA

Annexon, Inc

Ansun BioPharma Inc

Antiva Biosciences

Apexigen, Inc.

Aqualung Therapeutics Corp

ARCH Venture Partners LP

ARS Pharmaceuticals, Inc.

Ascentage Pharma group

Atomwise Inc.

Biopact Cellular Transport Inc

Blueberry Therapeutics Ltd.

Boxer Capital

BW Therapeutics LLC

Cadent Therapeutics

Carisma Therapeutics Inc.

Casdin Capital LLC

Casma Therapeutics, Inc.

Celsense Inc

CerFlux Inc

Chondrial Therapeutics LLC

Cormorant Asset Management LLC

Cowen Healthcare Investments

Decibel Therapeutics, Inc.

Deerfield Management

ElevateBio LLC

Emulate Inc.

EQRx Inc

Escient Pharmaceuticals, Inc.

Evox Therapeutics Ltd

Fidelity Management & Research

Foresite Capital Management LLC

Freeline Therapeutics

Galecto Biotech AB

Galera Therapeutics Inc

Generation Bio Corp

Heartseed Inc

Horama SA

Hotspot Therapeutics, Inc

Hoverink Biotechnologies Inc

ILiAD Biotechnologies, LLC

Immune-Onc Therapeutics, Inc.

Immunocore Ltd

Impact Therapeutics

InCarda Therapeutics, Inc.

InSightec Ltd

Intarcia Therapeutics Inc

Intensity Therapeutics, Inc.

iTeos Therapeutics SA

KAHR medical Ltd

Kaitai Capital

Kallyope Inc

Kleo Pharmaceuticals Inc

Ksq Therapeutics, Inc

Kymera Therapeutics LLC

Lilly Asia Ventures

Max Biopharma Inc

Medicxi Ventures (UK) LLP

Metacrine, Inc.

Minoryx Therapeutics

Modalis Therapeutics Corporation

Nanjing Legend Biotech Co Ltd

NBE-Therapeutics AG

Neuraly, Inc

Neurana Pharmaceuticals, Inc.

Neurotez Inc

NMD Pharma ApS

Nohla Therapeutics, Inc.

Novo Holdings AS

Oncoheroes Biosciences Inc

OncoResponse, Inc.

Orasis Pharmaceuticals

Orbimed Advisors LLC

Partner Therapeutics, Inc

Perceptive Advisors

Phylos Bioscience Inc

Pliant Therapeutics Inc

Polaris Partners LLC

Quentis Therapeutics, Inc.

RA Capital Management LLC

Rakuten Medical Inc

Rallybio, LLC

ReAlta Life Sciences Inc

Redmile Group LLC

Relay Therapeutics

RemeGen Ltd

Rgenix, Inc

Rheos Medicines, Inc.

Ripple therapeutics Corp

Rongchang Bio-Pharmaceutical Co., Ltd

Sen-Jam Pharmaceutical LLC

Senti Biosciences, Inc

Sirnaomics, Inc.

Slayback Pharma LLC

SQZ Biotech

StemBioSys Inc

Surveyor Capital Ltd

SutroVax Inc

Synthego Corporation

Tecnologia Regenerativa Qrem SL

Transcenta Holding Ltd

Vedanta Biosciences, Inc.

Velicept Therapeutics, Inc.

Vivo Capital LLC

Xilio Therapeutics Inc

XtalPi, Inc.